Bacthera and Seres Therapeutics plan to commercialize first live biotherapeutic product

A new manufacturing facility will become operational at Lonza’s Visp site in 2024

Related Articles

A man sits on the edge of his bed and holds his head and stomache as if in pain.

NUTRITION & HEALTH NEWS

The incidence of digestive problems and gastrointestinal disorders (GIDs) are on the rise globally, and some of those suffering from GIDs have reported that symptoms can... Read More

Two women doing yoga outside, relaxing.

NUTRITION & HEALTH NEWS

Consumers continue searching for supplements that support more than physical well-being, prioritizing holistic health benefits and looking for solutions in new health... Read More

Beyond the Headlines

NUTRITION & HEALTH NEWS

In nutrition news this week, Chr. Hansen’s probiotic DDS-1 was granted two new functional food claims by Health Canada, and Glycoguard launched a probiotic gel for... Read More

Woman shopping for nutraceuticals.

NUTRITION & HEALTH NEWS

As health and wellness continue to be top-of-mind for consumers, Innova Market Insights’ data suggest that nutraceutical and functional ingredient sales grew 7%... Read More

Man holding his knee.

NEW PRODUCT DEVELOPMENT

Voltaren, a brand of Haleon, recently unveiled two non-prescription pain supplements for joint health and mobility. According to the company, the products utilize... Read More

trans